Calcitonin PCD Pharma Franchise Company

Cafoli Lifecare offers a Calcitonin range of 2 nasal spray formulations, manufactured in WHO-GMP certified facilities. Distributors serving orthopaedic, endocrine and geriatric prescribers can secure district-wise monopoly franchise rights for this specialised bone-metabolism molecule with full promotional support.

What is Calcitonin?

Calcitonin (salmon calcitonin) is a peptide hormone that lowers blood calcium and inhibits osteoclast-mediated bone breakdown. Delivered as a nasal spray, it is used to preserve bone and relieve pain in certain bone disorders, and it also has a useful analgesic effect in acute vertebral osteoporotic fractures. Reference: PubChem - Calcitonin (salmon).

Available Forms

The Cafoli Calcitonin portfolio is offered as metered-dose Nasal Spray, a convenient non-injectable presentation for elderly patients. Contact us for current pack presentations and trade offers.

Therapeutic Applications

Calcitonin nasal spray is used in postmenopausal osteoporosis, hypercalcaemia, Paget disease of bone and for pain relief in acute osteoporotic vertebral fractures. Prescribers include orthopaedic surgeons, endocrinologists, rheumatologists and physicians managing bone health in the elderly.

Why Calcitonin is a High-Potential Molecule for Distributors

India has a very large and ageing osteoporosis population, and calcitonin nasal spray is a distinctive, specialist-recommended option valued for its bone-pain relief in acute vertebral fractures. As a niche, limited-competition, higher-value product, it lets a distributor add a premium bone-health line that complements the everyday calcium and vitamin D range.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Calcitonin (salmon)
2. MedlinePlus: Calcitonin nasal
3. PubMed: calcitonin in osteoporotic fracture pain